Cargando…
PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044094/ http://dx.doi.org/10.1186/1546-0096-11-S2-P271 |
_version_ | 1782319080893579264 |
---|---|
author | Gazda, A Kołodziejczyk, B Wierzbowska, M Gietka, P Szczygielska, I Rutkowska-Sak, L Ząbek, J Wojciechowska, B Kraska, A |
author_facet | Gazda, A Kołodziejczyk, B Wierzbowska, M Gietka, P Szczygielska, I Rutkowska-Sak, L Ząbek, J Wojciechowska, B Kraska, A |
author_sort | Gazda, A |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4044094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40440942014-06-17 PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012 Gazda, A Kołodziejczyk, B Wierzbowska, M Gietka, P Szczygielska, I Rutkowska-Sak, L Ząbek, J Wojciechowska, B Kraska, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044094/ http://dx.doi.org/10.1186/1546-0096-11-S2-P271 Text en Copyright © 2013 Gazda et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Gazda, A Kołodziejczyk, B Wierzbowska, M Gietka, P Szczygielska, I Rutkowska-Sak, L Ząbek, J Wojciechowska, B Kraska, A PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012 |
title | PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012 |
title_full | PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012 |
title_fullStr | PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012 |
title_full_unstemmed | PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012 |
title_short | PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012 |
title_sort | pres-final-2281: the incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in department of pediatric rheumatology, institute of rheumatology, warsaw in the years 2002-2012 |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044094/ http://dx.doi.org/10.1186/1546-0096-11-S2-P271 |
work_keys_str_mv | AT gazdaa presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 AT kołodziejczykb presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 AT wierzbowskam presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 AT gietkap presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 AT szczygielskai presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 AT rutkowskasakl presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 AT zabekj presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 AT wojciechowskab presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 AT kraskaa presfinal2281theincidenceofantiphospholipidantibodiesinchildrenwithjuvenileonsetlupuserythematosustreatedindepartmentofpediatricrheumatologyinstituteofrheumatologywarsawintheyears20022012 |